NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 899,442 Value ($000) $31,552 Avg Close $36.39 Range $28.19 - $42.00
Q3 2025
Shares 768,520 Value ($000) $21,857 Avg Close $23.97 Range $17.97 - $28.91
Q2 2025
Shares 627,719 Value ($000) $11,368 Avg Close $18.24 Range $14.06 - $22.25
Q1 2025
Shares 398,143 Value ($000) $8,150 Avg Close $22.23 Range $17.18 - $26.80
Q4 2024
Shares 80,210 Value ($000) $2,061 Avg Close $21.24 Range $15.51 - $27.29
Q3 2024
Shares 130,240 Value ($000) $2,162 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 6,069 Value ($000) $117 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 48,279 Value ($000) $1,142 Avg Close $20.30 Range $11.18 - $26.35
Q4 2023
Shares 800 Value ($000) $9 Avg Close $9.16 Range $5.63 - $11.89
Q2 2023
Shares 183 Value ($000) $2 Avg Close $13.27 Range $11.03 - $17.00